$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway 원문보기

Cellular physiology and biochemistry, v.42 no.4, 2017년, pp.1603 - 1613  

Xiao, Yunbin (Academy of Pediatrics, University of South China, Hengyang, China) ,  Peng, Hongyan (Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China) ,  Hong, Chenliang (Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China) ,  Chen, Zhi (Department of Cardiology, Hunan Children&apos) ,  Deng, Xicheng (s Hospital, Changsha, China) ,  Wang, Aiping (Department of Cardiology, Hunan Children&apos) ,  Yang, Fang (s Hospital, Changsha, China) ,  Yang, Li (Department of Anatomy, School of Medicine, University of South China, Hengyang, China) ,  Chen, Chen (Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China) ,  Qin, Xuping (Institute of Pharmacy and Pharmacology, University of South China, Hengyang, China)

Abstract AI-Helper 아이콘AI-Helper

AbstractBackground/Aims: The enhanced proliferation of pulmonary arterial smooth muscle cells (PASMCs) is a central pathological component in pulmonary arterial hypertension (PAH). Both the Warburg effect and platelet-derived growth factor (PDGF) are involved in the proliferation of PASMCs. However,...

주제어

참고문헌 (27)

  1. 1. Noureddine H, Gary-Bobo G, Alifano M, Marcos E, Saker M, Vienney N, Amsellem V, Maitre B, Chaouat A, Chouaid C, Dubois-Rande JL, Damotte D, Adnot S: Pulmonary artery smooth muscle cell senescence is a pathogenic mechanism for pulmonary hypertension in chronic lung disease. Circ Res 2011; 109:543-553. 21719760 10.1161/CIRCRESAHA.111.241299 

  2. 2. Chung WJ, Park YB, Jeon CH, Jung JW, Ko KP, Choi SJ, Seo HS, Lee JS, Jung HO: Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension. J Korean Med Sci 2015; 30:1429-1438. 26425039 10.3346/jkms.2015.30.10.1429 

  3. 3. Koppenol WH, Bounds PL, Dang CV: Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11:325-337. 21508971 10.1038/nrc3038 

  4. 4. Vander Heiden MG, Cantley LC, Thompson CB: Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029-1033. 19460998 10.1126/science.1160809 

  5. 5. Paulin R, Michelakis ED: The metabolic theory of pulmonary arterial hypertension. Circ Res 2014; 115:148-164. 24951764 10.1161/CIRCRESAHA.115.301130 

  6. 6. Rehman J, Archer SL: A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension. Adv Exp Med Biol 2010; 661: 171-185. 20204730 10.1007/978-1-60761-500-2_11 

  7. 7. Berghausen E, ten Freyhaus H, Rosenkranz S: Targeting of platelet-derived growth factor signaling in pulmonary arterial hypertension. Handb Exp Pharmacol 2013; 218: 381-408. 24092349 10.1007/978-3-642-38664-0_16 

  8. 8. Theisen CS, Wahl JK 3rd, Johnson KR, Wheelock MJ: NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility. Mol Biol Cell 2007; 18: 1220-1232. 17229887 10.1091/mbc.E06-10-0960 

  9. 9. Li L, Xu M, Li X, Lv C, Zhang X, Yu H, Zhang M, Fu Y, Meng H, Zhou J: Platelet- derived growth factor-B (PDGF-B) induced by hypoxia promotes the survival of pulmonary arterial endothelial cells through the PI3K/Akt/Stat3 pathway. Cell Physiol Biochem 2015; 35:441-451. 25613241 10.1159/000369709 

  10. 10. Courtnay R, Ngo DC, Malik N, Ververis K, Tortorella SM, Karagiannis TC: Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K. Mol Biol Rep 2015; 42:841-851. 25689954 10.1007/s11033-015-3858-x 

  11. 11. Yang X, Cheng Y, Li P, Tao J, Deng X, Zhang X, Gu M, Lu Q, Yin C: A lentiviral sponge for miRNA-21 diminishes aerobic glycolysis in bladder cancer T24 cells via the PTEN/PI3K/AKT/mTOR axis. Tumour Biol 2015; 36:383-391. 25266796 10.1007/s13277-014-2617-2 

  12. 12. Cottrill KA, Chan SY: Metabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effect. Eur J Clin Invest 2013; 43:855-865. 23617881 10.1111/eci.12104 

  13. 13. Archer SL, Gomberg-Maitland M, Maitland ML, Rich S, Garcia JG, Weir EK: Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF- 1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. Am J Physiol Heart Circ Physiol 2008; 294:H570-578. 18083891 10.1152/ajpheart.01324.2007 

  14. 14. Perez J, Hill BG, Benavides GA, Dranka BP, Darley-Usmar VM: Role of cellular bioenergetics in smooth muscle cell proliferation induced by platelet-derived growth factor. Biochem J 2010; 428:255-267. 20331438 10.1042/BJ20100090 

  15. 15. Werle M, Kreuzer J, Hofele J, Elsasser A, Ackermann C, Katus HA, Vogt AM: Metabolic control analysis of the Warburg-effect in proliferating vascular smooth muscle cells. J Biomed Sci 2005; 12:827-834. 16205843 10.1007/s11373-005-9010-5 

  16. 16. Houssaini A, Abid S, Mouraret N, Wan F, Rideau D, Saker M, Marcos E, Tissot CM, Dubois-Rande JL, Amsellem V, Adnot S: Rapamycin reverses pulmonary artery smooth muscle cell proliferation in pulmonary hypertension. Am J Respir Cell Mol Biol 2013; 48:568-577. 23470622 10.1165/rcmb.2012-0429OC 

  17. 17. Chan SY, Loscalzo J: Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol 2008; 44:14-30. 17950310 10.1016/j.yjmcc.2007.09.006 

  18. 18. Wang AP, Li XH, Yang YM, Li WQ, Zhang W, Hu CP, Zhang Z, Li YJ: A Critical Role of the mTOR/eIF2alpha Pathway in Hypoxia-Induced Pulmonary Hypertension. PLoS One 2015; 10:e0130806. 26120832 10.1371/journal.pone.0130806 

  19. 19. Takahashi J, Orcholski M, Yuan K, de Jesus Perez V: PDGF-dependent beta-catenin activation is associated with abnormal pulmonary artery smooth muscle cell proliferation in pulmonary arterial hypertension. FEBS Lett 2016; 590:101-109. 26787464 10.1002/1873-3468.12038 

  20. 20. Godinas L, Guignabert C, Seferian A, Perros F, Bergot E, Sibille Y, Humbert M, Montani D: Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword? Semin Respir Crit Care Med 2013; 34:714-724. 24037637 10.1055/s-0033-1356494 

  21. 21. Dahal BK, Heuchel R, Pullamsetti SS, Wilhelm J, Ghofrani HA, Weissmann N, Seeger W, Grimminger F, Schermuly RT: Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-beta. Pulm Circ 2011; 1:259-268. 22034611 10.4103/2045-8932.83448 

  22. 22. Robey RB, Hay N: Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol 2009; 19:25-31. 19130886 10.1016/j.semcancer.2008.11.010 

  23. 23. Hitosugi T, Fan J, Chung TW, Lythgoe K, Wang X, Xie J, Ge Q, Gu TL, Polakiewicz RD, Roesel JL, Chen GZ, Boggon TJ, Lonial S, Fu H, Khuri FR, Kang S, Chen J: Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell 2011; 44:864-877. 22195962 10.1016/j.molcel.2011.10.015 

  24. 24. Sutendra G, Dromparis P, Bonnet S, Haromy A, McMurtry MS, Bleackley RC, Michelakis ED: Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFalpha contributes to the pathogenesis of pulmonary arterial hypertension. J Mol Med (Berl) 2011; 89:771-783. 21809123 10.1007/s00109-011-0762-2 

  25. 25. Semenza GL: Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta 2011; 1813:1263-1268. 20732359 10.1016/j.bbamcr.2010.08.006 

  26. 26. Peng H, Xiao Y, Deng X, Luo J, Hong C, Qin X: The Warburg effect: A new story in pulmonary arterial hypertension. Clin Chim Acta 2016; 461:53-58. 27475978 10.1016/j.cca.2016.07.017 

  27. 27. Woo YM, Shin Y, Lee EJ, Lee S, Jeong SH, Kong HK, Park EY, Kim HK, Han J, Chang M, Park JH: Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF -1alpha Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells. PLoS One 2015; 10:e0132285. 26158266 10.1371/journal.pone.0132285 

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로